“immunotherapy” Archives

in
Entry Author Date Location
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Houston Technology Center Chooses Banker, Civic Leader as New CEO 01/09/17 Texas
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap 09/09/16 National
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact 06/29/16 Boston
Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial 06/21/16 National
Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones 06/20/16 National
Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M 06/13/16 Seattle
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
With CRISPR in Humans On The Horizon, Will the Public Back Intellia? 04/29/16 Boston
Page 1 of 5 next page »